Efficacy of SLT in Patients With Insufficient IOP Control Under Maximum Tolerated Drug Therapy (Eye Drops)

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT00801658
• Date of registration: 02/12/2008
• Prospective Registration: No
• Primary sponsor: University of Zurich
• Public title: Efficacy of SLT in Patients With Insufficient IOP Control Under Maximum Tolerated Drug Therapy (Eye Drops)
• Date of first enrolment: January 2008
• Target sample size: 30
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT00801658
• Study type: Interventional
• Study design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: Phase 4

Countries of recruitment

Switzerland

Contacts

• Name: 01 Studienregister MasterAdmins
• Affiliation: UniversitaetsSpital Zuerich

Key inclusion & exclusion criteria

Inclusion criteria: Patients with

- primary open angle glaucoma (including normal tension glaucoma)

- pseudoexfoliation glaucoma

- pigment dispersion glaucoma

Exclusion criteria: previous intraocular surgery closed angle glaucoma pediatric glaucoma
inflammatory or uveitic glaucoma unclear view of the trabecular meshwork



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Glaucoma

Intervention(s)

Device: selective Laser Trabeculoplasty (SLT)

Primary Outcome(s)

IOP lowering effect of SLT in a special patient group [Time Frame: 1 day, 1 , 3, 6 , 12 months postoperative]

Secondary ID(s)

FunkSLT

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ellex Medical Pty, 82 Gilbert Str., Adelaide, SA 5000